P1.03F.03 Utility of Patient-Derived Xenograft and Xenograft-Derived Organoid Models with EGFR Mutation to Study EGFR-TKI Resistance.
Back to course
Pdf Summary
Asset Subtitle
Nhu-An Pham
Meta Tag
Speaker Nhu-An Pham
Topic Tumor Biology – Translational Biology
Keywords
lung adenocarcinoma
tyrosine kinase inhibitors
osimertinib resistance
EGFR mutations
patient-derived xenografts
xenograft-derived organoids
drug screening
cancer therapy
genetic alterations
Princess Margaret Cancer Centre
Powered By